Robert Frantz

Professor of Medicine

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert Frantz is a Professor of Medicine at Mayo Clinic, USA. His research focuses on pulmonary arterial hypertension, exploring topics such as risk prediction, treatment strategies, and exercise capacity indicators. Recent publications include investigations into the benefits of vasodilators, the role of echocardiographic parameters, and the characteristics of patients at risk for or with known pulmonary hypertension.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (11)

Vallerie McLaughlin

UNITED STATES

View details

Nancy Casanova

Research Associate Professor

University of Florida

UNITED STATES

View details

Richard Kronmal

UNITED STATES

View details

anna hemnes

Associate Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Sue Duval

University of Minnesota

UNITED STATES

View details

Michele D’Alto

ITALY

View details

Michael Patrick Gray

University of Sydney

AUSTRALIA

View details

Erika B. Rosenzweig

Professor of Pediatrics (in Medicine)

Columbia University Irving Medical Center

UNITED STATES

View details

Thenappan Thenappan

University of Minnesota

UNITED STATES

View details

Rebecca R. Vanderpool

Assistant Professor

Ohio State University

UNITED STATES

View details

Kara Bischoff

Associate Professor

University of California, San Francisco

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Frantz

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension

Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension

Attenuated benefit to vasodilators in patients with pulmonary arterial hypertension and high probability of heart failure with preserved ejection fraction

Characteristics of Daily Walking Bouts as Valid and Reliable Indicators of Exercise Capacity in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)

Editorial on “Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center”

The frequency and predictors of pulmonary rehabilitation referrals among patients with pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry

Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort

Risk stratification and treatment goals in pulmonary arterial hypertension

An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension

Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI

Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study

Using PAH‐SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease

SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation

Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association Registry

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository

The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension

Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

Safety of macitentan for the treatment of pulmonary hypertension: Real‐world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)

The Oracle of the Auricle?

Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension

COUNTERPOINT: Should the New Definition of PH Be the Clinical Practice Standard? No

Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS Program

Collaborators (11)

Vallerie McLaughlin

Nancy Casanova

Richard Kronmal

anna hemnes

Sue Duval

Michele D’Alto

Michael Patrick Gray

Erika B. Rosenzweig

Thenappan Thenappan

Rebecca R. Vanderpool

Kara Bischoff

Make your next move.